|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
AniGenics Inc., of Chicago, entered a three-year, $17.5 million collaborative research program sponsored by Genome Canada, of Ottawa, Quebec. AniGenics will perform the research with the Veterinary Infectious Disease Organization in Saskatoon; the University of Saskatchewan at Saskatoon; and the University of British Columbia, Simon Fraser University and Inimex Pharmaceuticals Inc., all in Vancouver. The program, which begins this summer, focuses on infectious disease genomics of cattle and poultry.
Biogen Inc., of Cambridge, Mass., saw its stock rise $9.11 Friday, or 22.6 percent, following the Dermatologic and Ophthalmic Drugs Advisory Committee 8-to-2 ...